More Unnecessary Imaginary Worlds – Part 3: Cystic Fibrosis and the Institute for Clinical and Economic Review’s Draft Evidence Report

INNOVATIONS in pharmacy
doi 10.24926/iip.v11i1.3056
Full Text
Abstract

Available in full text

Date
Authors
Publisher

University of Minnesota

Related search

Applying the Institute for Clinical and Economic Review’s (ICER) Methodology to Canada: An Improved Way to Take Into Consideration Drug Affordability Challenges?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Integrating Clinical and Economic Evidence in Clinical Guidelines: More Needed Than Ever!

Journal of Evaluation in Clinical Practice
Health PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cystic Fibrosis: Economic Impact Upon the Family.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1971English

Liver Transplantation in Adult Cystic Fibrosis: Clinical, Imaging and Pathological Evidence of Obliterative Portal Venopathy

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Multiple Sclerosis and the Comparative Value Disease Modifying Therapy Report of the Institute for Clinical and Economic Review (ICER)

INNOVATIONS in pharmacy
2017English

Validating Imaginary Worlds? The AdViSHE Assessment Tool

INNOVATIONS in pharmacy
2017English

Cystic Fibrosis and Myocardial Fibrosis.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1977English

Imaging of Cystic Fibrosis Lung Disease and Clinical Interpretation

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren
MedicineNuclear MedicineRadiologyImaging
2016English

Clinical Management of Children and Adults With Cystic Fibrosis

BMJ
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy